SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001493152-18-013022
Filing Date
2018-09-07
Accepted
2018-09-07 17:25:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 162397
  Complete submission text file 0001493152-18-013022.txt   164117
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83793 | Film No.: 181060904
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108
Business Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108 617-904-9195
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

IRS No.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G